| 000 | 01761 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515100139.0 | ||
| 264 | 0 | _c20080424 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1041-6102 | ||
| 024 | 7 |
_a10.1017/S1041610207006485 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRyan, Joanne | |
| 245 | 0 | 0 |
_aHormonal treatment, mild cognitive impairment and Alzheimer's disease. _h[electronic resource] |
| 260 |
_bInternational psychogeriatrics _cFeb 2008 |
||
| 300 |
_a47-56 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdiagnosis |
| 650 | 0 | 4 |
_aCognition Disorders _xdiagnosis |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xmethods |
| 650 | 0 | 4 |
_aEstrogens _xadministration & dosage |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMemory Disorders _xdiagnosis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aProgestins _xtherapeutic use |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
| 650 | 0 | 4 |
_aResearch Design _xstandards |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aScali, Jaqueline | |
| 700 | 1 | _aCarriere, Isabelle | |
| 700 | 1 | _aRitchie, Karen | |
| 700 | 1 | _aAncelin, Marie-Laure | |
| 773 | 0 |
_tInternational psychogeriatrics _gvol. 20 _gno. 1 _gp. 47-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S1041610207006485 _zAvailable from publisher's website |
| 999 |
_c17586594 _d17586594 |
||